Invictus MD (CSE:IMH) has closed a previously announced non-brokered private placement of 11,428,571 units for gross proceeds of $12 million.
As quoted in the press release:

Each unit entitles the holder to one common share and one-half warrant exercisable for one additional common share at $1.75 expiring in 18 months. If the closing price of the common share is equal to or greater than $2.75 for a period of ten (10) consecutive trading days, the Company will have the right to accelerate the expiry.
In connection with the private placement, the Company paid finders’ fees to Eventus Capital Corp. of $607,475 and 578,548 finder’s warrants. The finder’s warrants have the same terms as each whole warrant issued in the private placement.
The Company intends to use the proceeds of the private placement to carry out its acquisition strategy including the most recently announced transactions with a cultivation facility in Las Vegas, Nevada as well as AB Laboratories Inc. (“AB Labs”), a licensed producer in Canada under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
The Las Vegas, Nevada cultivation facility is owned by GreenTec Nevada Holdings, a subsidiary of the GreenTec Bio-Pharmaceuticals Group. The existing cultivation facility has the capacity to produce 1,250 kg’s annually. The expansion plan has the potential to reach 2,500kg annually.
AB Labs is currently working on an expansion plan through AB Farms Inc. (“AB Farms”) to acquire 100 acres in Hamilton, Ontario for cannabis cultivation under the ACMPR. Invictus MD has agreed to provide the required capital to fund the purchase of the land and the construction of the buildings related to this expansion plan. The expansion of AB Farms will enable the company enough expansion capacity to compete with the current top tier Licensed Producers.

Click here to read the full press release.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less